On 10 August 2026, China NT Pharma Group Company Limited released its latest corporate communication package—comprising the Circular dated the same day, the Notice of Extraordinary General Meeting (EGM) and the related Form of Proxy—through the company’s website (www.ntpharma.com) and the HKEXnews portal (www.hkexnews.hk).

The pharmaceutical group is prioritising digital dissemination and “strongly recommends” shareholders access the electronic versions. Registered shareholders who encounter difficulties with online access, or who prefer hard copies, may obtain printed materials free of charge by completing and returning the enclosed Reply Form to the Hong Kong branch share registrar, Tricor Investor Services Limited, at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by emailing 1011-ecom@vistra.com. A prepaid mailing label is provided for local postal returns.

Shareholders are responsible for supplying a functional email address to receive future electronic notifications. Until a valid address is on record, the company will continue to dispatch physical Notices of Publication and actionable communications. The current election on delivery format remains effective until 31 December 2026 unless amended by written notice.

Enquiries can be directed to Tricor Investor Services via the hotline at +852 2980 1333, Monday to Friday, 9:00 a.m.–6:00 p.m. (excluding Hong Kong public holidays).

The announcement was authorised by Executive Director Ng Tit on behalf of the board of China NT Pharma Group Company Limited.